Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells

Oncogene

Volumn 25, Issue 58, 2006, Pages 7565-7576

  Huang, Y ^a   Li, X ^b   Jiang, J ^a   Frank, S J ^a,c,d  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

EGFR; Phosphorylation; Prolactin; Signaling; Synergy

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; COLLAGEN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; JANUS KINASE 2; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROLACTIN; PROTEIN TYROSINE PHOSPHATASE; STAT5 PROTEIN; THREONINE;

ADENOHYPOPHYSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST DUCT; CANCER CELL; CANCER GROWTH; CELL MOTILITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; ENHANCER REGION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LACTATION; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PHOSPHOTHREONINE; PROLACTIN; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

EID: 33845528355     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209740     Document Type: Article

References (100)

1. Acosta JJ, Munoz RM, Gonzalez L, Subtil-Rodriguez A, Dominguez-Caceres MA, Garcia-Martinez JM et al. (2003). Mol Endocrinol 17: 2268-2282.
2. Alessi DT, Cuenda A, Cohen P, Dudley DT, Saltiel A. (1995). J Biol Chem 270: 27489-27494.
3. Alroy I, Yarden Y. (1997). FEBS Lett 410: 83-86.
4. Anderson E, Ferguson JE, Morten H, Shalet SM, Robinson EL, Howell A. (1993). Eur J Cancer 29A: 209-217.
5. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN et al. (1993). Cell 74: 237-244.
6. Badache A, Hynes NE. (2001). Cancer Res 61: 383-391.
7. Bagowski CP, Stein-Gerlach M, Choidas A, Ullrich A. (1999). EMBO J 18: 5567-5576.
8. Bao J, Alroy I, Waterman H, Schejter ED, Brodie C, Gruenberg J et al. (2000). J Biol Chem 275: 26178-26186.
9. Bargmann CI, Hung MC, Weinberg RA. (1986). Nature 319: 226-230.
10. Bazan JF. (1990). Proc Natl Acad Sci USA 87: 6934-6938.
11. Ben-Jonathan N, Liby K, McFarland M, Zinger M. (2002). Trends Endocrinol Metab 13: 245-250.
12. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. (1996). Endocr Rev 17: 639-669.
13. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B et al. (1988). Cancer Res 48: 1238-1243.
14. Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ. (2000). Breast Cancer Res 2: 203-210.
15. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. (1998). Endocrinol Rev 19: 225-268.
16. Bonneterre J, Mauriac L, Weber B, Roche H, Fargeot P, Tubiana-Hulin M et al. (1988). Eur J Cancer Clin Oncol 24: 1851-1853.
17. Boonstra J, Rijken P, Humbel B, Cremers F, Verkleij A, van Bergen en Henegouwen P. (1995). Cell Biol Int 19: 413-430.
18. Burke P, Schooler K, Wiley HS. (2001). Mol Biol Cell 12: 1897-1910.
19. Campbell GS, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA, Carter-Su C. (1994). Proc Natl Acad Sci USA 91: 5232-5236.
20. Ceresa BP, Schmid SL. (2000). Curr Opin Cell Biol 12: 204-210.
21. Chen NY, Holle L, Li W, Peirce SK, Beck MT, Chen WY. (2002). Int J Oncol 20: 813-818.
22. Chen WS, Lazar CS, Poenie M, Tsien RY, Gill GN, Rosenfeld MG. (1987). Nature 328: 820-823.
23. Chughtai N, Schimchowitsch S, Lebrun JJ, Ali S. (2002). J Biol Chem 277: 31107-31114.
24. Clevenger CV, Furth PA, Hankinson SE, Schuler LA. (2003). Endocrinol Rev 24: 1-27.
25. Clevenger CV, Kline JB. (2001). Lupus 10: 706-718.
26. Das R, Vonderhaar BK. (1996a). Breast Cancer Res Treat 40: 141-149.
27. Das R, Vonderhaar BK. (1996b). Oncogene 13: 1139-1145.
28. Davis RJ, Czech MP. (1985). Proc Natl Acad Sci USA 82: 1974-1978.
29. Di Fiore PP, De Camilli P. (2001). Cell 106: 1-4.
30. Dudley DT, Pang L, Decker SJ, Bridges A, Saltiel AR. (1995). Proc Natl Acad Sci USA 92: 7686-7689.
31. Eisenberg A, Biener E, Charlier M, Krishnan RV, Djiane J, Herman B et al. (2004). FEBS Lett 565: 139-142.
32. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS et al. (1998). J Biol Chem 273: 18623-18632.
33. Fenton SE, Sheffield LG. (1993). Mol Biol Cell 4: 773-780.
34. Fenton SE, Sheffield LG. (1997). Exp Cell Res 236: 285-293.
35. Frank SJ, Yi W, Zhao Y, Goldsmith JF, Gilliland G, Jiang J et al. (1995). J Biol Chem 270: 14776-14785.
36. Freeman ME, Kanyicska B, Lerant A, Nagy G. (2000). Physiol Rev 80: 1523-1631.
37. Gibson S, Tu S, Oyer R, Anderson SM, Johnson GL. (1999). J Biol Chem 274: 17612-17618.
38. Ginsburg E, Vonderhaar BK. (1995). Cancer Res 55: 2591-2595.
39. Goffin V, Bernichtein S, Touraine P, Kelly PA. (2005). Endocrinol Rev 26: 400-422.
40. Goffin V, Binart N, Touraine P, Kelly PA. (2002). Annu Rev Physiol 64: 47-67.
41. Goffin V, Touraine P, Pichard C, Bernichtein S, Kelly PA. (1999). Mol Cell Endocrinol 151: 79-87.
42. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. (1997). EMBO J 16: 1647-1655.
43. Grimm SL, Seagroves TN, Kabotyanski EB, Hovey RC, Vonderhaar BK, Lydon JP et al. (2002). Mol Endocrinol 16: 2675-2691.
44. Gutzman JH, Nikolai SE, Rugowski DE, Watters JJ, Schuler LA. (2005). Mol Endocrinol 19: 1765-1778.
45. Gutzman JH, Rugowski DE, Schroeder MD, Watters JJ, Schuler LA. (2004). Mol Endocrinol 18: 3064-3075.
46. Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C et al. (1999). J Natl Cancer Inst 91: 629-634.
47. Haraguchi S, Good RA, Engelman RW, Greene S, Day NK. (1997). Mol Cell Endocrinol 129: 145-155.
48. Harari P. (2004). Endocrinol Relat Cancer 11: 689-708.
49. Heisermann GJ, Gill GN. (1988). J Biol Chem 263: 13152-13158.
50. Holbro T, Civenni G, Hynes NE. (2003). Exp Cell Res 284: 99-110.
51. Horseman ND. (1999). J Mammary Gland Biol Neoplasia 4: 79-88.
52. Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ et al. (2001). Dev Dyn 222: 192-205.
53. Huang Y, Chang Y, Wang X, Jiang J, Frank SJ. (2004a). Endocrinology 145: 3297-3306.
54. Huang Y, Kim SO, Jiang J, Frank SJ. (2003). J Biol Chem 278: 18902-18913.
55. Huang Y, Kim S-O, Yang N, Jiang J, Frank SJ. (2004b). Mol Endocrinol 18: 1471-1485.
56. Hunter T, Ling N, Cooper JA. (1984). Nature 311: 480-483.
57. Jiang J, Liang L, Kim SO, Zhang Y, Mandler R, Frank SJ. (1998). Biochem Biophys Res Commun 253: 774-779.
58. Johnson JL, Fenton S, Sheffield LG. (1996). J Biol Chem 271: 21574-21578.
59. Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ. (1996). EMBO J 15: 254-264.
60. Kassenbrock CK, Hunter S, Garl P, Johnson GL, Anderson SM. (2002). J Biol Chem 277: 24967-24975.
61. Kim SO, Houtman JC, Jiang J, Ruppert JM, Bertics PJ, Frank SJ. (1999). J Biol Chem 274: 36015-36024.
62. Kim SO, Jiang J, Yi W, Feng GS, Frank SJ. (1998). J Biol Chem 273: 2344-2354.
63. Kim SO, Loesch K, Wang X, Jiang J, Mei L, Cunnick JM. (2002). Endocrinology 143: 4856-4867.
64. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. (1989). Proc Natl Acad Sci USA 86: 9193-9197.
65. Laskin JJ, Sandler AB. (2004). Cancer Treat Rev 30: 1-17.
66. Li X, Huang Y, Jiang J, Frank SJ. (2005). Endocrine Society Program and Abstracts, 87th Annual Meeting. Endocrine Society Press: San Diego, CA, pp 3-91, abstract.
67. Lichtner RB. (2003). Biomed Pharmacother 57: 447-451.
68. Lichtner RB, Menrad A, Sommer A, Klar U, Schneider MR. (2001). Cancer Res 61: 5790-5795.
69. Lin CR, Chen WS, Kruiger W, Stolarsky LS, Weber W, Evans RM et al. (1984). Science 224: 843-848.
70. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. (1997). Genes Dev 11: 179-186.
71. Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly PA et al. (2000a). Oncogene 19: 4695-4705.
72. Llovera M, Touraine P, Kelly PA, Goffin V. (2000b). Exp Gerontol 35: 41-51.
73. Maus MV, Reilly SC, Clevenger CV. (1999). Endocrinology 140: 5447-5450.
74. McMurray RW, Weidensaul D, Allen SH, Walker SE. (1995). J Rheumatol 22: 2084-2091.
75. Mendelsohn J, Baselga J. (2000). Oncogene 19: 6550-6565.
76. Mendelsohn J, Baselga J. (2003). J Clin Oncol 21: 2787-2799.
77. Nicholson RI, Gee JM, Harper ME. (2001). Eur J Cancer 37: S9-S15.
78. Northwood IC, Gonzalez FA, Wartmann M, Raden DL, Davis RJ. (1991). J Biol Chem 266: 15266-15276.
79. Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM, Buckley S. (1993). Nature 366: 473-475.
80. Qiu Y, Ravi L, Kung HJ. (1998). Nature 393: 83-85.
81. Quijano Jr VJ, Sheffield LG. (1998). J Biol Chem 273: 1200-1207.
82. Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV. (1997). Endocrinology 138: 5555-5560.
83. Rui H. (2000). In: Oppenheim JJ, Feldman M (eds). Cytokine Reference On-Line, vol. website:www.academicpress.com/cytokinereference,24-h free access. Academic Press, Harcourt: London, UK, pp 267-283.
84. Rui H, Kirken RA, Farrar WL. (1994). J Biol Chem 269: 5364-5368.
85. Schroeder MD, Symowicz J, Schuler LA. (2002). Mol Endocrinol 16: 45-57.
86. Shilo BZ. (2003). Exp Cell Res 284: 140-149.
87. Stern DF. (2000). Breast Cancer Res 2: 176-183.
88. Takishima K, Friedman B, Fujiki H, Rosner MR. (1988). Biochem Biophys Res Commun 157: 740-746.
89. Takishima K, Griswold-Prenner I, Ingebritsen T, Rosner MR. (1991). Proc Natl Acad Sci USA 88: 2520-2524.
90. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M et al. (1991). J Biol Chem 266: 15771-15781.
91. Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C et al. (1998). J Clin Endocrinol Metab 83: 667-674.
92. Vonderhaar BK. (1999). Endocr Relat Cancer 6: 389-404.
93. Wennbo H, Kindblom J, Isaksson OG, Tornell J. (1997). Endocrinology 138: 4410-4415.
94. Wiepz GJ, Houtman JC, Cha D, Bertics PJ. (1997). J Cell Physiol 173: 44-53.
95. Wiley HS. (2003). Exp Cell Res 284: 78-88.
96. Wiley HS, Shvartsman SY, Lauffenburger DA. (2003). Trends Cell Biol 13: 43-50.
97. Xie W, Paterson AJ, Chin E, Nabell LM, Kudlow JE. (1997). Mol Endocrinol 11: 1766-1781.
98. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M et al. (1997). Nature 390: 91-96.
99. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M et al. (1998). Endocrinol J 45: 27-31.
100. Yamauchi T, Yamauchi N, Ueki K, Sugiyama T, Waki H, Miki H et al. (2000). J Biol Chem 275: 33937-33944.